<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>Science and Education Publishing</PublisherName>
<JournalTitle>American Journal of Biomedical Research</JournalTitle>
<Issn>2328-3955</Issn>
<Volume>1</Volume>
<Issue>4</Issue>
<PubDate PubStatus="epublish">
<Year>2013</Year>
<Month>11</Month>
<Day>15</Day>
</PubDate>
</Journal>
<ArticleTitle>Combined Support-Vector-Machine-Based Virtual Screening and Docking Method for the Discovery of IMP-1 Metallo-β-Lactamase Inhibitors Supplementary Data</ArticleTitle>
<FirstPage>120</FirstPage>
<LastPage>131</LastPage>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Jiao</FirstName>
<LastName>Chen</LastName>
</Author>
<Author>
<FirstName>Yifang</FirstName>
<LastName>Liu</LastName>
</Author>
<Author>
<FirstName>Mi</FirstName>
<LastName>Fang</LastName>
</Author>
<Author>
<FirstName>Hui</FirstName>
<LastName>Chen</LastName>
</Author>
<Author>
<FirstName>Xingzhen</FirstName>
<LastName>Lao</LastName>
</Author>
<Author>
<FirstName>Xiangdong</FirstName>
<LastName>Gao</LastName>
</Author>
<Author>
<FirstName>Heng</FirstName>
<LastName>Zheng</LastName>
<Affiliation>School of Life Science and Technology, China Pharmaceutical University, Nanjing, P.R. China</Affiliation>
</Author>
<Author>
<FirstName>Wenbing</FirstName>
<LastName>Yao</LastName>
<Affiliation>School of Life Science and Technology, China Pharmaceutical University, Nanjing, P.R. China</Affiliation>
</Author>

</AuthorList>
<ArticleIdList>
<ArticleId IdType="pii">AJBR2013148</ArticleId>
<ArticleId IdType="doi">10.12691/ajbr-1-4-8</ArticleId>
</ArticleIdList>
<History>
<PubDate PubStatus="received">
<Year>2013</Year>
<Month>11</Month>
<Day>07</Day>
</PubDate>
<PubDate PubStatus="revised">
<Year>2013</Year>
<Month>11</Month>
<Day>13</Day>
</PubDate>
<PubDate PubStatus="accepted">
<Year>2013</Year>
<Month>11</Month>
<Day>15</Day>
</PubDate>
</History>
<Abstract>Metallo-¦-lactamases can hydrolyze a broad range of ¦-lactam antibiotics and no effective inhibitors could be used in the clinic. Therefore, the discovery of metallo-¦-lactamase inhibitors has attracted much attention in recent years. In this study, a support vector machine (SVM) that separates compounds into positives and negatives, combined with docking method was employed for virtual screening of IMP-1 metallo-¦-lactamase inhibitors. Eight of the twenty five selected compounds were purchased for in vitro assays. Among them, four compounds show inhibitory potency against IMP-1. Two of them are found to have novel scaffolds, implying a good potential for further optimization.</Abstract>
</Article>
</ArticleSet>
